Full name
AMGEN BIOTECHNOLOGIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
AMGEN BIOTECHNOLOGIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. PUŁAWSKA 145, 02-715 WARSZAWA
TAX ID5252517917
Rate company:
AMGEN BIOTECHNOLOGIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5252517917
KRS0000397231
Share capital5,000.00 zł
address
UL. PUŁAWSKA 145, 02-715 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5252517917
REGON
145827419
KRS
0000397231
Legal form
limited liability company
Register Address
UL. PUŁAWSKA 145, 02-715 WARSZAWA
Date of registration in KRS
2011-09-26
Date of commencement of economic activity
2011-09-26
Act signature
WA.XIII NS-REJ.KRS/66787/24/564
Pkd codes
46.18.Z - Agents specialised in the sale of other particular products
70.22.Z - Business and other management consultancy activities
85.60.Z - Educational support activities
Payer VAT status
Active
Vat list bank account(s)
PL42 1030 1508 0000 0008 1601 2007 
PL20 1030 1508 0000 0008 1601 2015 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 3,4 | 3,5 | 3,7 | 5,8 |
EBITDA | 4,4 | 4,4 | 4,5 | 0,5 |
Short time liabilities | 2,6 | 3 | 2,1 | -31,2 |
Equity capital | 7,1 | 9,8 | 12,7 | 29,5 |
Operating profit (EBIT) | 3,4 | 3,5 | 3,6 | 1,5 |
Assets | 15,8 | 19,2 | 21,3 | 10,6 |
Net profit (loss) | 2,6 | 2,6 | 2,9 | 9,7 |
Cash | 10,3 | 15 | 0,1 | -99,6 |
Net income from sale | 48,6 | 51 | 50,4 | -1,1 |
Liabilities and provisions for liabilities | 8,6 | 9,4 | 8,6 | -9 |
Working assets | 12,6 | 16,8 | 19,4 | 15,3 |
Depreciation | 1 | 0,9 | 0,9 | -3,4 |
% | % | % | p.p. | |
Profitability of capital | 35,9 | 26,9 | 22,8 | -4,1 |
Equity capital to total assets | 45,3 | 50,9 | 59,6 | 8,7 |
Gross profit margin | 6,9 | 6,9 | 7,4 | 0,5 |
EBITDA Margin | 9,1 | 8,7 | 8,8 | 0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 19 | 22 | 15 | -7 |
Current financial liquidity indicator | 1.4584811925888062 | 0,1 | ||
Net dept to EBITDA | -2.3366172313690186 | 1,4 |
Financial statements
01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download pdfShow more (4)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Astat sp. z o.o.
Poznań
Cat sp. z o.o.
Chorzów
ELANSTIL S.C. GRZEGORZ P.AUERBACH, SEBASTIAN G.AUERBACH
BIELSKO-BIAŁA
EUROPACK-TRADE
MIKOŁÓW
Pterus Artur Jaroszuk
Bialystok
NETPORT
Szczecin
PROFITALIANS SP Z O.O.
Zawada
"CARBON STEEL" sp. z o.o.
Bydgoszcz
XTPLS Sp. z o.o.
WROCŁAW